Congress allows the practice in case of drug shortage and, as per the OFA suit, deems compounding an efficient, effective, and appropriate means to maintain access to a drug despite supply constraints
Wegovy is the version of semaglutide marketed to treat obesity by the longtime market leader in sales of GLP-1 diabetes and obesity treatments Novo Nordisk (NASDAQ Copenhagen: NOVO-B) , which also markets semaglutide to treat type 2 diabetes under the name Ozempic
Additionally, semaglutide suppresses glucagon secretion from pancreatic alpha cells, thereby reducing hepatic glucose production
Inability to keep any liquids down due to persistent vomiting
Hart, R
The more informed you are, the more productive the conversation will be, and the safer the combination will be in practice